Working… Menu

A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03132324
Recruitment Status : Terminated (This study is terminated due to a business decision not to pursue INCB059782 in Sickle Cell Disease indication.)
First Posted : April 27, 2017
Last Update Posted : October 28, 2019
Information provided by (Responsible Party):
Incyte Corporation

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : October 3, 2018
Actual Study Completion Date : October 3, 2018